Mircera (Genentech, Inc.)
Welcome to the PulseAid listing for the Mircera drug offered from Genentech, Inc.. This Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | Methoxy polyethylene glycol-epoetin beta |
| SUBSTANCE NAME: | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-10-24 |
| END MARKETING DATE: | 2019-05-31 |
Mircera HUMAN PRESCRIPTION DRUG Details:
| Item Description | Mircera from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(ug/.3mL) |
| START MARKETING DATE: | 2014-10-24 |
| END MARKETING DATE: | 2019-05-31 |
| PRODUCT ID: | 0004-0401_b6ab110d-70a9-4fdb-9808-79db877596d0 |
| PRODUCT NDC: | 0004-0401 |
| APPLICATION NUMBER: | BLA125164 |
Other METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA Pharmaceutical Manufacturers / Labelers:
